An updated narrative review on the management of the most common oncological and hematological emergencies

Jafari, 2020, Oncological emergencies from pathophysiology and diagnosis to treatment: a narrative review, Soc Work Public Health, 35, 689, 10.1080/19371918.2020.1824844 Higdon, 2018, Oncologic emergencies: recognition and initial management, Am Fam Phys, 97, 741 Thandra, 2020, Oncologic emergencies-the old, the new, and the deadly, J Intensive Care Med, 35, 3, 10.1177/0885066618803863 Halfdanarson, 2017, Emergencies in hematology and oncology, Mayo Clin Proc, 92, 609, 10.1016/j.mayocp.2017.02.008 Spring, 2021, Oncologic emergencies: traditional and contemporary, Crit Care Clin, 37, 85, 10.1016/j.ccc.2020.08.004 Asonitis, 2019, Pathophysiology and management of hypercalcemia in malignancy: a review of the literature, Horm Metab Res, 51, 770, 10.1055/a-1049-0647 Zagzag, 2018, Hypercalcemia and cancer: differential diagnosis and treatment, CA Cancer J Clin, 68, 377, 10.3322/caac.21489 Bhandari, 2019, Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis [published correction appears in Med Oncol. 2019 Nov 1;36(12):100], Med Oncol, 36, 90, 10.1007/s12032-019-1315-8 Goltzman, 2019, Nonparathyroid hypercalcemia, Front Horm Res, 51, 77, 10.1159/000491040 Turner, 2017, Hypercalcaemia - presentation and management, Clin Med, 17, 270, 10.7861/clinmedicine.17-3-270 Sheehan, 2020, Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy, Med Hypotheses, 143, 10.1016/j.mehy.2020.110149 Chukir, 2020, Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors, J Clin Endocrinol Metab, 105, e1115, 10.1210/clinem/dgz278 Pepe, 2020, Diagnosis and management of hypocalcemia, Endocrine, 69, 485, 10.1007/s12020-020-02324-2 Drake, 2021, Calcium Klemencic, 2019, Diagnosis and management of oncologic emergencies, West J Emerg Med, 20, 316, 10.5811/westjem.2018.12.37335 Kim, 2019, A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy, J Oncol Pharm Pract, 25, 1787, 10.1177/1078155218812945 Russell, 2020, Tumor lysis syndrome, Pediatr Rev, 41, 20, 10.1542/pir.2018-0243 Rahmani, 2019, Current understanding of tumor lysis syndrome, Hematol Oncol, 37, 537, 10.1002/hon.2668 Williams, 2019, Tumor lysis syndrome, Arch Pathol Lab Med, 143, 386, 10.5858/arpa.2017-0278-RS Cheung, 2020, Tumor lysis syndrome in childhood malignancies, Drugs Context, 9, 10.7573/dic.2019-8-2 Greguska, 2021, Managing tumor lysis syndrome, JAAPA, 34, 10, 10.1097/01.JAA.0000723908.23506.85 Wagner, 2017, Oncologic metabolic emergencies, Hematol Oncol Clin N Am, 31, 941, 10.1016/j.hoc.2017.08.002 Boussios, 2018, Metastatic spinal cord compression: unraveling the diagnostic and therapeutic challenges, Anticancer Res, 38, 4987, 10.21873/anticanres.12817 Patnaik, 2020, Metastatic spinal cord compression, Br J Hosp Med, 81, 1, 10.12968/hmed.2019.0399 Lawton, 2019, Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review, J Clin Oncol, 37, 61, 10.1200/JCO.2018.78.1211 Ropper, 2017, Acute spinal cord compression, N Engl J Med, 376, 1358, 10.1056/NEJMra1516539 Macdonald, 2019, Malignant spinal cord compression, J R Coll Physicians Edinb, 49, 151, 10.4997/jrcpe.2019.217 Sadiq, 2021, Advanced lung cancer presenting with malignant pericardial effusion, Clin Case Rep, 9, e04179, 10.1002/ccr3.4179 Neves, 2021, Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: a case report, J Med Case Rep, 15, 543, 10.1186/s13256-021-03085-w Azarbal, 2017, Pericardial Effusion, Cardiol Clin, 35, 515, 10.1016/j.ccl.2017.07.005 Chahine, 2021, Pericardial involvement in cancer, Am J Cardiol, 145, 151, 10.1016/j.amjcard.2020.12.092 Azizi, 2020, Superior vena cava syndrome, JACC Cardiovasc Interv, 13, 2896, 10.1016/j.jcin.2020.08.038 Klein-Weigel, 2020, Superior vena cava syndrome, Vasa, 49, 437, 10.1024/0301-1526/a000908 Zimmerman, 2018, Rapid fire: superior vena cava syndrome, Emerg Med Clin N Am, 36, 577, 10.1016/j.emc.2018.04.011 Horiuchi, 2019, Superior vena cava syndrome, QJM, 112, 743, 10.1093/qjmed/hcz055 Karakhanian, 2019, Superior vena cava syndrome: endovascular management, J Vasc Bras, 18, 10.1590/1677-5449.180062 Azizi, 2021, Endovascular therapy for superior vena cava syndrome: a systematic review and meta-analysis, EClinicalMedicine, 37, 10.1016/j.eclinm.2021.100970 Seligson, 2021, Superior vena cava syndrome Boiten, 2020, Ixazomib treatment of IgA multiple myeloma with hyperviscosity syndrome, Clin Lymphoma Myeloma Leuk, 20, e832, 10.1016/j.clml.2020.06.016 Khan, 2017, Oncologic mechanical emergencies, Hematol Oncol Clin N Am, 31, 927, 10.1016/j.hoc.2017.08.001 Miller, 2021, Hyperviscosity syndrome in rheumatoid arthritis, J Rheumatol, 48, 788, 10.3899/jrheum.200591 Weaver, 2020, Hyperviscosity syndrome in paraprotein secreting conditions including waldenstrom macroglobulinemia, Front Oncol, 10, 815, 10.3389/fonc.2020.00815 Halaseh, 2022, Hyperviscosity syndrome in IgA multiple myeloma, QJM, 115, 30, 10.1093/qjmed/hcab175 Klemencic, 2019, Diagnosis and management of oncologic emergencies, West J Emerg Med, 20, 316, 10.5811/westjem.2018.12.37335 Gertz, 2018, Acute hyperviscosity: syndromes and management, Blood, 132, 1379, 10.1182/blood-2018-06-846816 Emerson, 2018, Rapid fire: acute blast crisis/hyperviscosity syndrome, Emerg Med Clin N Am, 36, 603, 10.1016/j.emc.2018.04.005 Shenoy, 2017, Cardiovascular oncologic emergencies, Cardiology, 138, 147, 10.1159/000475491 Geha, 2018, Blood is thicker: hyperviscosity syndrome, Am J Med, 131, 916, 10.1016/j.amjmed.2018.02.022 Kebudi, 2018, Febrile neutropenia in children with cancer: approach to diagnosis and treatment, Curr Pediatr Rev, 14, 204, 10.2174/1573396314666180508121625 Patel, 2017, Febrile neutropenia, JAMA Oncol, 3, 1751, 10.1001/jamaoncol.2017.1114 Ferreira, 2017, Managing febrile neutropenia in adult cancer patients: an integrative review of the literature, Rev Bras Enferm, 70, 1301, 10.1590/0034-7167-2016-0247 Schmidt-Hieber, 2019, Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation, Expert Rev Anti Infect Ther, 17, 983, 10.1080/14787210.2019.1573670 Aguilar-Guisado, 2017, Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (how long study): an open-label, randomised, controlled phase 4 trial, Lancet Haematol, 4, e573, 10.1016/S2352-3026(17)30211-9 Borrelli, 2019, Radiation-induced skin fibrosis: pathogenesis, current treatment options, and emerging therapeutics, Ann Plast Surg, 83, S59, 10.1097/SAP.0000000000002098 Threlkeld, 2021, Neuro-oncologic emergencies, Neurol Clin, 39, 545, 10.1016/j.ncl.2021.01.012 Khan, 2020, Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review, Semin Cancer Biol, 64, 93, 10.1016/j.semcancer.2019.06.012 Dougan, 2021, Understanding and treating the inflammatory adverse events of cancer immunotherapy, Cell, 184, 1575, 10.1016/j.cell.2021.02.011 Kennedy, 2020, A review of cancer immunotherapy toxicity, CA Cancer J Clin, 70, 86, 10.3322/caac.21596 Kim, 2020, Guidelines for the management of extravasation, J Educ Eval Health Prof, 17, 21, 10.3352/jeehp.2020.17.21